95 related articles for article (PubMed ID: 9781645)
1. Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis).
Franc B; Rosenberg-Bourgin M; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Lange F; Labat-Moleur F; Le Bodic MF; Patey M; Beauchet A; Saint-André JP; Hejblum G; Viennet G
Hum Pathol; 1998 Oct; 29(10):1078-84. PubMed ID: 9781645
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
Modigliani E; Cohen R; Campos JM; Conte-Devolx B; Maes B; Boneu A; Schlumberger M; Bigorgne JC; Dumontier P; Leclerc L; Corcuff B; Guilhem I
Clin Endocrinol (Oxf); 1998 Mar; 48(3):265-73. PubMed ID: 9578814
[TBL] [Abstract][Full Text] [Related]
3. [Causes of death in patients with medullary cancer of the thyroid. GETC. Groupe d'Etude des Tumeurs à Calcitonine].
Cohen R; Buchsenschutz B; Estrade P; Gardet P; Modigliani E
Presse Med; 1996 Nov; 25(37):1819-22. PubMed ID: 8991034
[TBL] [Abstract][Full Text] [Related]
4. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
5. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
6. [Medullary thyroid carcinoma: evolution of concepts].
Franc B; Modigliani E
Arch Anat Cytol Pathol; 1998; 46(1-2):100-11. PubMed ID: 9754365
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of survival without clinical recurrences in medullary thyroid carcinoma: apropos of 52 operated cases].
Raffaitin P; Hamy A; Mirallie E; Meurette G; Duplessis R; Lemeunier P; Murat A; Le Bodic M; Le Neel JC; Paineau J; Visset J
Ann Endocrinol (Paris); 1999 Dec; 60(6):435-42. PubMed ID: 10617796
[TBL] [Abstract][Full Text] [Related]
8. Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a Calcitonine.
Franc B; Rosenberg-Bourgin M; Auvert B; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Labat-Moleur F; Le Bodic MF
Henry Ford Hosp Med J; 1992; 40(3-4):261-3. PubMed ID: 1362419
[TBL] [Abstract][Full Text] [Related]
9. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
[TBL] [Abstract][Full Text] [Related]
11. [Histological variants of thyroid medullary carcinoma].
Raĭkhlin NT; Smirnova EA; Satylganov IZh
Arkh Patol; 2001; 63(3):10-4. PubMed ID: 11452645
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
Schlumberger M; Abdelmoumene N; Delisle MJ; Couette JE
Br J Cancer; 1995 Feb; 71(2):363-5. PubMed ID: 7530987
[TBL] [Abstract][Full Text] [Related]
13. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract][Full Text] [Related]
18. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
Dinneen SF; Valimaki MJ; Bergstralh EJ; Goellner JR; Gorman CA; Hay ID
J Clin Endocrinol Metab; 1995 Jul; 80(7):2041-5. PubMed ID: 7608252
[TBL] [Abstract][Full Text] [Related]
19. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
20. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]